knowledge -WSS

knowledge

author：focus 2025-09-03 11:51:42 - browse：234

John Crowley pictured with his daughter Megan Crowley — health policy news from STAT — John Crowley pictured with his daughter Megan. Crowley family

WASHINGTON — The Biotechnology Innovation Organization has chosen longtime biotech executive and rare disease advocate John Crowley as its new CEO, the organization announced Tuesday.

Crowley came to biotech when his children were diagnosed with a rare genetic neuromuscular disease. He started working at Bristol Myers Squibb, and started Novazyme, which was eventually successful in creating an enzyme replacement therapy for Pompe disease. He later started and worked for several different biotech companies, most recently with Amicus Therapeutics, which had a drug approved to treat the disease in September.

The trade association’s board chair, Ted Love, served on the board of the company.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： AI gets buy

Wikipedia

leisure time

WSS

Surgery pushed Ben Carson to fame

Adopting new red light myopia treatments may be short

In diabetes hearing, Sanders takes on a new foe: food makers

STAT letters to the editor on burnt

Gene therapy for Afghan refugees’ infant will be fully covered

In diabetes hearing, Sanders takes on a new foe: food makers

focus

knowledge

Wikipedia

Affirmative action in medical school literally saved lives

Congenital heart disease patients face new threat of heart failure

Medicare details structure of new drug price negotiation program

Patients' immediate access to test results puts radiologists in a bind

Medicare details structure of new drug price negotiation program

Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

Malaria cases in Florida and Texas: Here’s what you need to know

A single Democrat is willing to weaken Medicare negotiation power

State Dept. review finds Biden bears some blame for Afghanistan failures

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

explore

STAT Event – Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D

Why CTE doesn’t keep Americans from enjoying the Super Bowl

Roche to buy Carmot Therapeutics, developer of obesity drugs

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

Readout LOUD: Venture capital, Gilead, and more M&A

AI gets buy

explore

Wikipedia

leisure time

entertainment